Visual and anatomical outcomes following intravitreal aflibercept in eyes with recalcitrant neovascular age-related macular degeneration: 12-month results

Medicine and Dentistry

• Aflibercept 100%
• Patient 80%
• Retinal Detachment 60%
• Bevacizumab 40%
• Age Related Macular Degeneration 40%
• Best Corrected Visual Acuity 40%
• Subretinal Fluid 40%
• Ranibizumab 40%
• Wet Macular Degeneration 40%
• Injection 40%
• Visual Acuity 20%
• Cyst Fluid 20%
• Optical Coherence Tomography 20%

Nursing and Health Professions

• Retina Detachment 60%
• Bevacizumab 40%
• Ranibizumab 40%
• Best Corrected Visual Acuity 40%
• Volume 40%
• Inpatient 40%
• Height 40%
• Injection 40%
• Thickness 40%
• Age Related Macular Degeneration 40%
• Wet Macular Degeneration 40%
• Subretinal Fluid 40%
• Visual Acuity 20%
• Cyst Fluid 20%

INIS

• eyes 80%
• patients 60%
• fluids 60%
• pigments 60%
• resolution 40%
• volume 40%
• reduction 40%
• injection 40%
• height 40%
• thickness 40%
• cysts 20%